Please disable your adblock and script blockers to view this page

Why The FDA's Approval Of A New Alzheimer's Drug Should Worry You

Positivity     50%   
   Negativity   50%
The New York Times
Write a review: The Huffington Post

Aduhelm, a pricey treatment meant to stall mental decline, may be a case study in everything that's wrong with how America manages prescription drugs.

As said here by Jonathan Cohn